What we know so far: It is called retatrutide, a new therapy known as tri-agonist which works at the hormone level, and is designed to help control blood sugar, slow stomach emptying, and reduce appetite
Ongoing phase 3 trials are expected to provide more comprehensive data on retatrutides potential as a therapeutic option for obesity and its related complications
Final Thoughts Semaglutide and tirzepatide are valuable tools for weight management in midlife, supported by strong trial data
taking NAC signals the body to produce more glutathione from available raw materials
He is a health contributor to Fox News Radio and has appeared on Fox & Friends, Fox News, NBC News, CBS News, NewsMax TV, WPIX, and Wall Street Journal Live
Meanwhile, a number of researchers elsewhere had also begun to uncover evidence pointing to a relationship between hormones produced in the intestine and pancreatic islets